Tag: TNBC

Home / TNBC

Categories

Pembrolizumab has been approved by the FDA for high-risk early-stage triple-negative breast cancer

August 2021: Pembrolizumab (Keytruda, Merck) was approved by the FDA for high-risk, early-stage triple-negative breast cancer (TNBC) as a neoadjuvant treatment in combination with chemotherapy, and la...
tnbc

Scan the code